Central African Republic vs Togo: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Central African Republic
- Togo
How they compare
Togo currently reports 5,494 deaths against 4,877 deaths in Central African Republic, a difference of 617 deaths.
That makes Togo's figure about 1.1 times Central African Republic's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Togo ahead.
Central African Republic ranks 37th and Togo ranks 35th of 157 countries.
Togo has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Central African Republic | Togo | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 795.06 deaths | 940.75 deaths | 145.68 deaths | Togo |
| 2010s | 2,868 deaths | 4,416 deaths | 1,547 deaths | Togo |
| 2020s | 4,591 deaths | 5,603 deaths | 1,013 deaths | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Central African Republic or Togo?
- Togo, at 5,494 deaths against 4,877 deaths in Central African Republic as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Central African Republic and Togo?
- 617 deaths, with Togo ahead.
- How many years of comparable data are there for Central African Republic and Togo?
- 35 years are reported by both, from 1990 to 2024.
- How do Central African Republic and Togo rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Central African Republic ranks 37th and Togo ranks 35th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.